ExThera Medical Corporation
$1.5M 15 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Invivyd Inc
Invivyd Inc reported $1,522,593.99 across General Payments, Research, and Ownership to 268 physicians and teaching hospitals across 325 transactions.
- $1.5M
- All-tracks total
- 325
- Transactions
- 268
- Recipients
- #520
- of 1,925 companies
Invivyd Inc reported $1,522,593.99 across all CMS Open Payments tracks (General + Research + Ownership) to 268 physicians and teaching hospitals in Program Year 2024 - ranking #520 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $70,506.52, averaging $5.7K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer invivyd-inc Invivyd Inc
$1.5M · #520/1,925 · 0.0% industry · PY2024
- TOT $1.5M
- RANK #520
- SHARE 0.0%
- TXN 325
- RCP 268
- CAT 4
- GEN $70.5K
- TOP1 11.3%
- PY 2024
Volume peers
Nearest volume peer: ExThera Medical Corporation ($1.5M)
Invivyd Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Invivyd Inc
In Program Year 2024, Invivyd Inc reported $1,522,593.99 in payments to 268 physicians and teaching hospitals across 325 individual transactions, an average of $4.7K per transaction and $5.7K per recipient. That total places Invivyd Inc at rank #520 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
Of the 4 general-payment categories charted below, "Consulting Fee" is the largest at $39.7K across 21 transactions, 56.3% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 4 types of general payments, Invivyd Inc's largest category was "Consulting Fee" at $39.7K - 56.3% of General Payments.
Invivyd Inc reports 4 general-payment categories - the top three are Consulting Fee (56.3%), Space Rental or Facility Fees (29.4%), and Food and Beverage (7.5%). The remaining 1 category make up 6.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Invivyd Inc divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $39.7K | 21 | 56.3% |
| Space Rental or Facility Fees | $20.8K | 9 | 29.4% |
| Food and Beverage | $5.3K | 236 | 7.5% |
| Compensation for Services Other Than Consulting | $4.8K | 2 | 6.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $25,323.51 (35.9%) of $70,506.52 in this company's General Payments records across 243 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Invivyd Inc
The five named recipients with the highest reported General Payments from this company
- 1
Scripps Green Hospital
$8,000.00 across 2 reported transactions
- 2
Ucsf Medical Center
$6,000.00 across 2 reported transactions
- 3
Mayo Clinic Hospital Rochester
$5,004.00 across 2 reported transactions
- 4
Cedric Spak
$3,694.51 across 4 reported transactions
- 5
Kassem Safa
$2,625.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Invivyd Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Invivyd Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Invivyd Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Collegium Pharmaceutical, Inc.
$1.5M 36,863 recipients
Compare payment profiles
Fresenius Kabi USA, LLC
$1.5M 8,126 recipients
Compare payment profiles
Balt USA, LLC
$1.5M 1,737 recipients
Compare payment profiles
Instylla, Inc.
$1.5M 124 recipients
Compare payment profiles
VectivBio AG
$1.5M 10 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.